Alkermes reviewing options after Lundbeck makes unsolicited bid for Avadel
14/11/2025 13:02
Nov 14 (Reuters) - Alkermes ALKS.O said on Friday it is reviewing its options with advisers after Avadel Pharmaceuticals AVDL.O disclosed it had received an unsolicited takeover proposal from Danish pharmaceutical company Lundbeck. In October, Alkermes had said it will buy Avadel in a deal worth up to $2.1 billion, aiming to enter the sleep medicine market (Reporting by Kamal Choudhury in Bengaluru; Editing by Krishna Chandra Eluri) ((Kamal.Choudhury@thomsonreuters.com;))